LANNETT CO INC FDA Approval ANDA 091662

ANDA 091662

LANNETT CO INC

FDA Drug Application

Application #091662

Application Sponsors

ANDA 091662LANNETT CO INC

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORAL12.5MG0HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE

FDA Submissions

N/A; Not ApplicableORIG1AP2012-01-27

Submissions Property Types

ORIG1Null15

CDER Filings

LANNETT CO INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91662
            [companyName] => LANNETT CO INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROCHLOROTHIAZIDE","activeIngredients":"HYDROCHLOROTHIAZIDE","strength":"12.5MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDROCHLOROTHIAZIDE","submission":"HYDROCHLOROTHIAZIDE","actionType":"12.5MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.